In organ diseases, current studies in liver diseases have not been able to determine whether CYP downregulation is caused by a decrease of CYP content or not, and in renal diseases it was not possible to identify whether the modulation of CYP activity was rather due to elimination issues (Farrell et al., 1979; Yang et al., 2003). This evidence concerns the gene PPIG and liver disorder.